EDUARDO MUÑOZ BLANCO2026-01-292026-01-29201210.1016/j.intimp.2012.05.0132-s2.0-84861991893https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/23883ImmunologyImmunology and AllergyPharmacologyImmunologyImmunology and AllergyPharmacologyThe anti-inflammatory effects of the 5-HT 3 receptor antagonist tropisetron are mediated by the inhibition of p38 MAPK activation in primary human monocytesresearch article